Results-Based Financing Impact Evaluation Health Facility 2017, Endline Survey
Burkina Faso, 2017
Get MicrodataCreated on
Dec 05, 2019
Last modified
Dec 05, 2019
Page views
78628
Downloads
106
F5_423 Si oui, sp (f5_423)
Data file: f5_jul19
Overview
Valid:
556
Invalid:
0
Type:
Discrete
Start:
349
End:
373
Width:
25
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 0 | 1 |
0.2%
|
|
| COMPRIMES VOIX ORALE | 1 |
0.2%
|
|
| CONTRACEPTIF INJECTABLE | 1 |
0.2%
|
|
| CONTRACEPTIF ORAL | 1 |
0.2%
|
|
| DEPOT PROVERA | 1 |
0.2%
|
|
| DIU | 2 |
0.4%
|
|
| DIU,injection | 1 |
0.2%
|
|
| DIU/Implant | 1 |
0.2%
|
|
| Depo Provera | 2 |
0.4%
|
|
| Depo provera | 5 |
0.9%
|
|
| Depoprovera | 4 |
0.7%
|
|
| Depot | 1 |
0.2%
|
|
| Depot Provera | 1 |
0.2%
|
|
| Depot provera | 2 |
0.4%
|
|
| Diu | 2 |
0.4%
|
|
| IMPLAN | 2 |
0.4%
|
|
| IMPLANT | 1 |
0.2%
|
|
| INJECTABLE | 5 |
0.9%
|
|
| INJECTATABLE | 1 |
0.2%
|
|
| INJECTION | 12 |
2.2%
|
|
| INJETION | 1 |
0.2%
|
|
| INPLANT | 1 |
0.2%
|
|
| Implant | 11 |
2%
|
|
| Implants | 2 |
0.4%
|
|
| Injectable | 8 |
1.4%
|
|
| Injectable(3mois) | 1 |
0.2%
|
|
| Injectables | 1 |
0.2%
|
|
| Injection | 3 |
0.5%
|
|
| Injections | 1 |
0.2%
|
|
| Jadel | 4 |
0.7%
|
|
| Le norplant | 1 |
0.2%
|
|
| NORPLAN | 1 |
0.2%
|
|
| NORPLANT | 6 |
1.1%
|
|
| Norplan | 3 |
0.5%
|
|
| Norplant | 5 |
0.9%
|
|
| PILILE | 1 |
0.2%
|
|
| PILLULE | 2 |
0.4%
|
|
| PRESERVATIF | 1 |
0.2%
|
|
| Pelule | 1 |
0.2%
|
|
| Pillule | 1 |
0.2%
|
|
| Pillules contraceptives | 1 |
0.2%
|
|
| Pilule | 1 |
0.2%
|
|
| Piques | 1 |
0.2%
|
|
| Piqure | 1 |
0.2%
|
|
| aural | 2 |
0.4%
|
|
| comprime | 1 |
0.2%
|
|
| comprimes | 1 |
0.2%
|
|
| comprimé | 2 |
0.4%
|
|
| comprimés | 1 |
0.2%
|
|
| condom masculin | 1 |
0.2%
|
|
| contraceptible injectable | 1 |
0.2%
|
|
| contraceptif injectable | 8 |
1.4%
|
|
| contraceptions oraux | 1 |
0.2%
|
|
| contraceptive injectable | 1 |
0.2%
|
|
| depo | 1 |
0.2%
|
|
| depo -provera | 1 |
0.2%
|
|
| depo pevera | 3 |
0.5%
|
|
| depo pravera | 1 |
0.2%
|
|
| depo provera | 31 |
5.6%
|
|
| depoprovera | 11 |
2%
|
|
| depoprovera et pillule | 1 |
0.2%
|
|
| depot | 3 |
0.5%
|
|
| depot porovera | 1 |
0.2%
|
|
| depot provera | 15 |
2.7%
|
|
| depot provera injectable | 1 |
0.2%
|
|
| depot proveral | 1 |
0.2%
|
|
| depotprovera | 1 |
0.2%
|
|
| diu | 3 |
0.5%
|
|
| dopoprovera | 1 |
0.2%
|
|
| fepo provera | 1 |
0.2%
|
|
| impla'ts | 1 |
0.2%
|
|
| implan | 3 |
0.5%
|
|
| implant | 46 |
8.3%
|
|
| implant,jadel | 1 |
0.2%
|
|
| implants | 4 |
0.7%
|
|
| injectable | 71 |
12.8%
|
|
| injectable (depo provera) | 1 |
0.2%
|
|
| injectable 3 mois | 1 |
0.2%
|
|
| injectable depo pevera | 1 |
0.2%
|
|
| injectables | 5 |
0.9%
|
|
| injectalble | 1 |
0.2%
|
|
| injection | 48 |
8.6%
|
|
| injection pour 3 mois | 1 |
0.2%
|
|
| injections | 6 |
1.1%
|
|
| inplan | 1 |
0.2%
|
|
| inplant | 1 |
0.2%
|
|
| inplants | 6 |
1.1%
|
|
| jadel | 14 |
2.5%
|
|
| jadelle | 11 |
2%
|
|
| l | 1 |
0.2%
|
|
| l'injectable | 1 |
0.2%
|
|
| l'injection | 1 |
0.2%
|
|
| les pilules | 1 |
0.2%
|
|
| les pilulle,le norplant, | 1 |
0.2%
|
|
| methode injectable | 1 |
0.2%
|
|
| microginon | 1 |
0.2%
|
|
| nord plant | 1 |
0.2%
|
|
| norplan | 12 |
2.2%
|
|
| norplan et piqure | 1 |
0.2%
|
|
| norplant | 32 |
5.8%
|
|
| nort plant | 1 |
0.2%
|
|
| nortplant | 1 |
0.2%
|
|
| oral | 1 |
0.2%
|
|
| pillule | 24 |
4.3%
|
|
| pillule contraceptive | 3 |
0.5%
|
|
| pillules | 11 |
2%
|
|
| pillules contraceptives | 4 |
0.7%
|
|
| pilule | 7 |
1.3%
|
|
| pilule contraceptive | 3 |
0.5%
|
|
| pilules | 3 |
0.5%
|
|
| pilulle contraceptive | 1 |
0.2%
|
|
| pique | 1 |
0.2%
|
|
| piqure | 3 |
0.5%
|
|
| preservatif | 1 |
0.2%
|
|
| preservatif feminin | 1 |
0.2%
|
|
| preservatif masculin | 1 |
0.2%
|
|
| preservatifs | 1 |
0.2%
|
|
| pulile | 2 |
0.4%
|
|
| sayana | 1 |
0.2%
|
|
| sayana press | 4 |
0.7%
|
|
| sterilet | 3 |
0.5%
|
|
| sterilin | 1 |
0.2%
|
|
| utilisation des condom | 1 |
0.2%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.